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Early and late Assessment of Stenosis Geometry 
After Coronary Arterial Stenting 
JACQUES PUEL, MD, YVES JUILLIERE, MD, MICHEL E. BERTRAND, MD, 
ANTHONY F. RICKARDS, MD, ULRICH SIGWART, MD, 
and PATRICK W. SERRUYS, MD 
Early and late rnodtftcations ofstenosis geometry 
after stenttng of coronary arteries were assessed. 
Morphologic changes were evaluated by quanttta- 
ttve coronary angtography (automated edge-detec- 
tion) and theoretical pressure drop across the dilat- 
ed and stented steno& was calculated from the 
Pokeuille formula, with turbulent resistances assum- 
ing a coronary blood flow of 1 or 3 ml/s. Eleven pa- 
tients (ages 41 to 69 years, mean 55) were studied 
before and after angioplasty, and immediately after 
stem implantation. The stented coronary artery was 
the left anterior descendi artery in g patients and 
the left circumflex in 2. Following stent implantation, 
an addftional increase in minimal luminal cross- 
sectional area of the dilated vessel was observed, 
suggesting that the &f-expanding stainless-steel 
endoprosthesk used had a dilating functii in addi- 
tion to tts stenting rote. Repeat angiography in 6 pa- 
ttents 3 months after stent implantation showed a 
decrease in the minimal iuminal cross-sectional 
area without a significant change in theoretic pres- 
sure decrease. This slight reduction in vessel caliber 
had no hemodynamtcalty stgntficant repercussions. 
Thus, stenting of coronary arteries following dilata- 
tion is a potentially valuable technique for prevent- 
ing both abrupt closure and late reduction in lumen 
diameter. 
(Am J Cardiol 1966;61:546-553) 
A lthough other techniques-pharmacologic,’ me- 
chanical and therma12*3-are currently under investi- 
gation, intravascular stenting of the dilated vessels has 
been proposed as an alternative approach for prevent- 
ing late restenosis after percutaneous transluminal 
coronary angioplasty (PTCA). Different prostheses 
have been developed and tested in animal experi- 
ments4-lo and, recently, intravascular stents have been 
implanted in patients. I1The endoprosthesis used in 
this open clinical trial consists of a self-expanding 
stainless-steel mesh that exerts a radial force on the 
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vascular wall. So far, there are no quantitative angio- 
graphic data indicating whether the endoluminal pros- 
thesis affects the immediate anatomic result of PTCA. 
On the other hand, because animal experiments have 
shown a neointimal proliferation totally encasing stent 
wires within a few weeks,8-10 it is crucial to demon- 
strate that the stenotic geometry of the human stented 
artery does not deteriorate at short-term follow-up. 
This study assesses early and delayed modifiaa- 
tions in stenotic geometry by quantitative coronary an- 
giography after stenting of coronary arteries in 11 pa- 
tients. 
Study population: The 11 patients ranged in age 
from 41 to 69 years [mean 55) and 8 were men. They 
were treated and investigated in the 3 following cen- 
ters: Department of Clinical and Experimental Cardi- 
ology, CHRU Rangueil, Toulouse, France [patients 6 - 
111, Catheterization Laboratory, Thoraxcenter, Rotter- 
dam, The Netherlands (patients l-3) and Department 
of Cardiology, Hospital Cardiologique, Lille, France 
(patients 4-5). Informed consent was obtained from 
each patient before the intervention. The endopros- 
thesis used in this study was provided by Medinvent 
SA. The dilated and stented coronary artery was the 
left anterior descending artery in 9 patients and the left 
circumflex artery in 2. This series of 11 patients includ- 
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TABLE I Morphologic Results Immediately After Stenting and Three Months Cater 
Minimal 
Extent Obstruction Cross-Sectional Diameter of Area of Reference Reference 
Pt Obstruction (mm) Diameter (mm) Area (mm*) Stenosis (%) Stenosis (%) Diameter (mm) Area (mm2) 
1 Pre-P 
Post-P 
Post-S 
2 Pre-P 
Post-P 
Post-S 
3 Pre-P 
Post-P 
Post-S 
4 Pre-P 
Post-P 
Post-S 
5 Pre-P 
Post-P 
Post-S 
6 Pre-P 
Post-P 
Post-S 
3 Mths 
7 Pre-P 
Post-P 
Post-S 
3 Mths 
8 Pre-P 
Post-P 
Post-S 
3 Mths 
9 Pm-P 
Post-P 
Post-S 
3 Mths 
10 Pre-P 
Post-P 
Post-S 
3 Mths 
11 Pre-P 
Post-P 
Post-S 
3 Mths 
Mean Pre-P (11) 
fSE Post-P (11) 
Post-S (11) 
Post-S (6) 
3 Mths (6) 
7.1 
6.1 
5.3 
a.2 
4.5 
5.4 
6.2 
3.6 
3.8 
5.5 
5.1 
4.9 
6.9 
6.4 
6.3 
6.2 
5.2 
6.2 
8.6 
8.1 
6.1 
7.0 
8.5 
8.6 
10.0 
9.4 
10.8 
10.0 
10.2 
a.7 
10.3 
5.6 
4.9 
7.2 
6.3 
7.6 
8.9 
7.5 
10.9 
7.3 f 0.4 
6.4 f 0.7 
6.5 f 0.5 
7.7 f 0.5 
9.2 f 0.7 3 
0.4 
1.8 
2.0 
0.7 
2.2 
2.3 
1.1 
1.6 
2.5 
0.7 
1.5 
2.2 
1.1 
1.7 
1.6 
0.9 
2.1 
2.4 
1.9 
1.6 
1.9 
2.8 
2.3 
1.5 
1.8 
2.3 
2.3 
1.6 
1.7 
2.0 
1.8 
0.8 
1.7 
2.7 
1.9 
2.0 
2.1 
2.4 
2.0 
1.1 f 0.1 
1.8 f 0.1 
2.3 f 0.1 3 
2.4 f 0.1 
2.0 f 0.1 
0.1 
2.6 
3.2 
0.4 
3.7 
4.3 
0.9 
2.0 
5.0 
0.4 
1.8 
3.7 
1.1 
2.3 
2.1 
0.7 
3.5 
4.5 
2.9 
2.0 
2.8 
6.2 
4.4 
1.8 
2.7 
4.3 
4.4 
1.9 
2.3 
3.3 
2.7 
0.5 
2.6 
6.0 
3.0 
3.1 
3.4 
4.9 
3.2 
1.2 f 0.3 
2.7 f 0.2 
4.3 f 0.4 
4.9 f 0.4 
3.4 f 0.3 
a2 
34 
27 
75 
23 
22 
56 
37 
10 
73 
41 
17 
61 
35 
40 
67 
21 
13 
30 
49 
24 
13 
26 
45 
38 
23 
25 
54 
44 
39 
46 
68 
31 
15 
37 
44 
36 
33 
42 
61 f4 
33 f 2 
23 f 3 3 
23 f 4 
34 f 3 
96 
56 
46 
94 
40 
39 
81 
61 
19 
93 
66 
32 
a3 
57 
64 
88 
37 
24 
51 
74 
42 
24 
44 
70 
61 
40 
43 
79 
69 
62 
70 
89 
52 
26 
61 
69 
59 
55 
65 
83 f 3 
54 f 3 
39 f 5 3 
39 f 7 
56 f 5 
2.6 
2.7 
2.8 
2.8 
2.8 
3.0 
2.4 
2.5 
2.8 
2.5 
2.6 
2.6 
2.8 
2.6 
2.7 
3.0 
2.6 
2.8 
2.7 
3.1 
2.5 
3.2 
3.1 
2.8 
3.0 
3.0 
3.1 
3.4 
3.0 
3.4 
3.4 
2.6 
2.5 
3.3 
3.1 
3.6 
3.2 
3.5 
3.5 
2.9 f 0.1 
2.7 f 0.1 
3.0 xt 0.1 
3.2 f 0.1 
3.1 f 0.1 
5.6 
5.8 
6.1 
6.0 
6.2 
7.2 
4.7 
5.2 
6.3 
5.0 
5.3 
5.4 
6.3 
5.5 
5.9 
6.9 
5.5 
6.0 
6.1 
7.7 
4.9 
8.2 
7.8 
6.2 
7.0 
7.3 
7.8 
9.3 
7.3 
8.9 
a.9 
5.3 
5.1 
8.8 
7.8 
10.1 
a.2 
9.9 
9.4 
6.6 f 0.5 
6.0 f 0.3 
7.3 f 0.4 
a.2 f 0.5 
8.0 f 0.5 
0 = not significant: 0 = p <0.05; 0 = p <O.Ol; n = p <0.005. 
Mths = months: P = PTCA; S = stent; SE = standard error. 
Radio-opaque Coaxial Central catheter External coaxial S&hole for Self-sealing valve 
catheter (plastic) 
FIGURE 1. Longitudinal section of the stent delivery catheter showing the “constrained” stent surrounded by the coaxial balloon. Following 
inflation of the balloon, the outer sheath of the coaxial system is retracted (arrow) to allow the stent to expand within the arterial lumen. 
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ed the first 6 consecutive patients who had an endo- 
prosthesis implanted in Toulouse for secondary pre- 
vention of restenosis and the first 5 patients with im- 
plants for primary prevention of restenosis in the pilot 
phase of a multicenter trial (Coronary Artery Stent 
Implant Study [CASIS]). No coronary spasm occurred 
at the time of endoprosthesis implantation. In patient 
7, a transient decrease from 3.1 to 2.5 mm in the refer- 
ence diameter was observed immediately after the di- 
FIGURE 2. Angiograms of a left anterior descending coronary artery 
(cranial projection) before (A) and after (13) angioplasty, and imme- 
diately after stent implantation (C), with superimposition of the 
automated contours of the coronary artery segment of interest. 
Underneath are shown the diameter function of the detected con- 
tours of the coronary artery, the minimal lumen diameter (verfical 
line) and the interpolated diameter function (horizontal line) from 
which the reference diameter is derived. 
lation and before stent implantation. This 0.6-mm 
change was greater than the average variability for this 
parameter and was therefore attributed to a diffuse 
spastic reaction. Among the 11 patients, 3 presented 
with an early thrombosis, 2 of them were successfully 
recanalized by thrombolytic therapy and PTCA; 6 
were reinvestigated after a 3-month follow-up. The 
medications at the time of the initial and 3-month an- 
giograms were identical and consisted of acetyl sali- 
cylic acid, dypiridamole, nitrates and calcium antago- 
nists. The subcutaneous heparin was discontinued 6 
weeks after the stent implantation. Repeat coronary 
angiography was performed 3 months after implanta- 
tion in 6 patients (5 men, 1 woman). 
Methods 
Description of the stent 11: The stent is woven from 
a surgical-grade stainless-steel alloy formulated ac- 
cording to the specifications ofthe International Stan- 
dards Organization. The prosthesis is geometrically 
stable, pliable and self-expanding. Its elastic and pli- 
able properties are such that the diameter can be sub- 
stantially reduced by moderate elongation. The pros- 
thesis can be constrained on a small-diameter delivery 
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catheter and, as the constraining membrane is progres- 
sively removed, the elastic device assumes its origi- 
nal (unconstrained) larger diameter. The constrained 
wire-mesh prosthesis is held at the distal end of the 
delivery catheter by a doubled-over membrane, the 
outer layer of which can be progressively withdrawn. 
Two radiopaque metal markers on the delivery cathe- 
ter facilitate identification fthe end of the prosthesis 
at the time of its deployment. The outer diameter of the 
loaded catheter system is 1.57 mm and prostheses able 
to expand to a diameter of 6.5 mm are mounted on this 
delivery device (Figure 1). 
In this study, unconstrained stent diameter ranged 
from 3.0 to 3.5 mm. The selection of stent sizes depend- 
ed upon the size of the arterial segment, taking into 
consideration that the stent in its unconstrained form 
must have a diameter 0.5 mm larger than the stented 
vessel. The prosthesis consisted of 16 wire filaments 
each 0.08-mm wide. 
Quantitative coronary angiography: The determi- 
nation of coronary arterial dimensions from %-mm 
cinefilm was performed with the computer-based Car- 
diovascular Angiography Analysis System.12-I5 In es- 
sence, boundaries of the relevant coronary artery 
segment are detected automatically from optically 
‘magnified and video-digitized regions of interest of a 
selected cineframe. The absolute diameter of the ste- 
nosis (in mm) is determined using the guiding catheter 
as a scaling device. The detected contours of the arteri- 
al and catheter segments are corrected for pincushion 
distortion.12J4 A computerized estimation of the origi- 
nal arterial dimension at the site of the obstruction is 
used to define the interpolated reference region.12J3 
The interpolated percentage area stenosis and the 
minimal luminal cross-sectional rea (mm21 are then 
calculated and averaged from, if possible, at least 2, 
preferably orthogonal projections. The length of the 
lesion is determined from the diameter function on the 
basis of a curvature analysis. 
The variability inobstruction diameter for short- (5 
min], medium- (60 min) and long-term (90 days] studies 
ranged from 0.22 mm for the short-term study to 0.36 
mm for the long-term study.13 In the long-term study 
group, the lack of significant variation in the mean 
difference of the minimal lumen diameters suggested 
that no detectable progression or regression of athero- 
sclerotic lesions had occurred over the go-day period. 
Therefore, a change greater than the total measure- 
ment variability of repeated coronary cineangiogra- 
phy and quantitative analysis (0.36 mm for obstruction 
diameter; i.e., 1 standard deviation of difference of 
duplicate measurements) was considered significant 
and indicative of restenosis. 
Hemodynamic assessment: The theoretic pressure 
drop was calculated using the arteriogram and digital 
computation, according to well-known formulas de- 
scribed in the literature:16-l8 Pgrad = Q . (Rp + Q. Rt) 
where Pgrad is the theoretic transstenotic pressure de- 
crease [mm Hg) over the stenosis, Q the mean coronary 
blood flow [ml/s], Rp the Poiseuille resistance and Rt 
the turbulent resistance. 
These resistances have been defined as follows: 
Rp = Cl . [length obstruction]/ 
[minimal cross-sectional real 
where C1 = 8 * 7r . (blood viscosity) 
with blood viscosity = 0.03 g/cm . s. 
Rt = CZ [l/minimal cross-sectional rea - l/ 
normal distal areal 
where C2 = (blood density]/0.266 
with blood density = 1.0 g/ems. 
The theoretic transstenotic pressure drop was cal- 
culated for a theoretic oronary blood flow of 0.5,l and 
3 ml/s. The Poiseuille and turbulent contributions to 
flow resistance were determined from stenotic geome- 
try assessed by quantitative coronary angiography. 
Statistical analysis: Comparisons between post- 
PTCA and post-stenting measurements and between 
post-stenting and 3-month follow-up measurements 
were carried out using the Student t test for paired 
observations. 
Results 
Early assessment immediately after stenting (Fig- 
ure 2A-C): The 11 patients were studied and a mean of 
MLCA (mm21 
J 
t t t 
Pre-PTCA Post-PTCA Post-STENT 
FIGURE 3. Changes in mlnimal luminal cross-sectional area 
(MLCA) between pre- (pre-PTCA) and post-angioplasty (post- 
PTCA), and immediately after stent implantation (post-WENT). 
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2.0 f 0.4 angiographic projections per lesion was ana- 
lyzed. The morphologic and hemodynamic data (mean 
f standard error of the mean as well as the individual 
values of the parameters for each patient), are listed in 
Table I and II, respectively. 
Stent implantation following PTCA resulted in an 
additional increase in minimal luminal cross-sectional 
area (Figure 3) and obstruction diameter, and a de- 
FIGURE 4. Angiograms of a left anterior descending coronary artery 
(lateral projection) before angioplasty (A), immediately after stent 
implantation (6) and after a d-month follow-up (C), with superimpo- 
sition of the automated contours of the coronary segment of inter- 
est. Underneath are shown the diameter function of the detected 
contours of the coronary artery, the minimal lumen diameter (verfi- 
cal Me) and the interpolated diameter function (horizonfal line) 
from which the reference diameter is derived. 
crease in stenotic percentage area and percentage di- 
ameter. This morphological improvement was associ- 
ated with a decrease in both the turbulent and Poi- 
seuille resistance as well as the theoretic transstenotic 
pressure decrease for a theoretic flow of 1 ml/s. It 
should be pointed out that the theoretic pressure gradi- 
ent assumed a uniform reduction in the lumen over the 
entire length of the stenosis which may not always 
apply to the complex morphology of a stenotic lesion. 
However, these data suggest that, immediately after 
PTCA, the endoprosthesis has a dilating function in 
addition to its stenting role. 
Late assessment after a three-month follow-up 
(Figure 4A-C): Six patients had repeat angiography at 3 
months with a mean of 2.0 f 0.2 angiographic projec- 
tions per lesion. The morphologic and hemodynamic 
data (mean f standard error or the mean, as well as the 
individual values of the parameters for each patient] 
are listed in Table I and II, respectively. 
The 3-month follow-up revealed a decrease in min- 
imal luminal cross-sectional rea (Figure 5), adecrease 
in obstruction diameter and an increase in stenot- 
ic percentage area and percentage diameter, when 
compared with the values recorded immediately af- 
ter stent implantation. The obstruction diameter de- 
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TABLE II Hemodynamic Results Immediately After Stenting and Three Months Later 
Poiseuille Turbulent Pressure Gradient Pressure Gradient Pressure Gradient 
Normal Distal Resistance Resistance (flow = 0.5 ml/s) (flow = 1 ml/s) (flow = 3 ml/s) 
Pt Area (mm*) (dynes . s 0 cm-5) (dynes . s . cmm5) (mm Hg) (mm 40 (mm W 
1 Pre-P 
Post-P 
Post-S 
2 Pre-P 
Post-P 
Post-S 
3 Pre-P 
Post-P 
Post-S 
4 Pre-P 
Post-P 
Post-S 
5 Pre-P 
Post-P 
Post-S 
6 Pre-P 
Post-P 
Post-S 
3 Mths 
7 Pre-P 
Post-P 
Post-S 
3 Mths 
8 Pre-P 
Post-P 
post-s 
3 Mths 
9 Pre-P 
Post-P 
Post-S 
3 Mths 
10 Pre-P 
Post-P 
post-s 
3 Mths 
11 Pre-P 
Post-P 
Post-S 
3 Mths 
Mean Pre-P (11) 
&SE Post-P (11) 
Post-S (11) 
Post-S (6) 
3 Mths (6) 
4.6 
5.6 
4.5 
4.3 
4.1 
6.0 
4.3 
5.1 
6.6 
2.7 
3.0 
4.5 
5.0 
4.8 
5.1 
6.1 
5.7 
5.8 
5.9 
6.4 
3.8 
6.0 
6.5 
4.6 
8.4 
6.1 
6.6 
7.7 
6.4 
6.8 
6.1 
3.8 
5.0 
8.8 
7.4 
7.4 
6.4 
8.9 
7.4 
5.2 f 0.5 
5.1 f 0.3 
6.3 f 0.4 3 
7.1 f 0.6 
6.6 f 0.2 
535 
0.7 
0.4 
39 
0.2 
0.2 
5.8 
0.7 
0.1 
26 
1.2 
0.3 
4.3 
0.9 
1.1 
13 
0.3 
0.2 
0.8 
1.5 
0.6 
0.1 
0.3 
1.9 
1.2 
0.4 
0.4 
2.8 
1.4 
0.6 
1.1 
17 
0.5 
0.1 
0.5 
0.6 
0.6 
0.2 
0.8 
59 f 48 
0.8fO.l 
0.3 f 0.1 3 
0.3 f 0.1 
0.7 f 0.1 3 
360 
0.2 
0.0 
19 
0.0 
0.0 
3.3 
0.3 
0.0 
17 
0.2 
0.0 
1.9 
0.2 
0.3 
6.0 
0.0 
0.0 
0.1 
0.4 
0.0 
0.0 
0.0 
0.4 
0.2 
0.0 
0.0 
0.6 
0.3 
0.1 
0.2 
11 
0.1 
0.0 
0.1 
0.1 
0.1 
0.0 
0.1 
38 zk 32 
0.2 l 0.0 
0.0 & 0.0 3 
0.0 f 0.0 
0.1 k 0.0 3 
121” (-4 
0.4 0.9 
0.2 0.4 
24 58 
0.1 0.2 
0.1 0.2 
3.7 9.1 
0.4 1.0 
0.0 0.1 
17 43 
0.6 1.4 
0.1 0.3 
2.6 6.2 
0.5 1.1 
0.6 1:4 
7.8 19 
0.1 0.3 
0.1 6.2 
0.4 0.9 
0.8 1.9 
0.3 0.6 
0.0 Q.l 
0.1 0.3 
1.0 2.2 
0.6 1.4 
0.2 0.4 
0.2 0.4 
1.5 3.4 
0.8 1.7 
0.3 0.7 
0.6 1.3 
11 28 
il.3 0.6 
0.0 0.1 
0.3 0.6 
0.3 0.7 
0.3 0.7 
0.1 0.2 
0.4 0.9 
7f2 17f6 
0.4 zk 0.1 3 0.9 f 0.1 0.1 f 0.0 0.4 f 0.1 3 
0.1 f 0.0 3 0.3 f 0.1 0.3 f 0.1 0.7 f 0.1 3 
C-4 
3.9 
1.2 
c-4 
0.6 
0.6 
47 
4.8 
(2; 
5.4 
0.9 
30 
4.5 
6.0 
92 
0.9 
0.6 
3.3 
8.1 
1.8 
0.3 
0.9 
9.1 
5.7 
1.3 
1.4 
1.4 
6.9 
2.7 
5.1 
(4 
2.4 
0.3 
2.4 
2.7 
2.7 
0.6 
3.3 
2gi 12 
3.6 zk 0.6 
1.8 zk 0.5 3 
1.0 i 0.4 
2.7 f 0.6 3 
* Theoretic pressure decrease calculated for a theoretic blood flow of 0.20 ml/s; (-) Theoretic pressure decrease greater than the mean aortic pressure. 
0 = not significant; 0 = p <0.05; 0 = p <O.Ol; n = p <0.005. 
Mths = months; P = PTCA; S = stent; SE = standard error. 
creased from 2.4 f 0.1 mm to 2.0 f 0.1 mm and the 
stenotic percentage diameter increased from 23 f 4% 
to 34 f 3%. The reduction in obstruction diameter was 
probably due to the neointimal proliferation, which 
theoretically should result in a diameter reduction of 
0.2 mm. The turbulent and Poiseuille resistance also 
increased significantly, but such an increase did not 
result in a hemodynamically significant pressure de- 
crease over the stent for theoretic flow rates of 1 to 3 
ml/s. 
Discussion 
A promising new approach to reduce the rate of 
restenosis is the implantation of an intravascular endo- 
prosthesis. The principle of introducing intraarterial 
grafts percutaneously was first described by Dotter in 
1969.5 During the last few years, variants of the original 
technique using thermal-shaped memory alloys,4-1s 
expanding spring steel spirals6 expanding stainless- 
steel stent$O and expanding woven stainless-steel 
meshes7-g have been reported in animal experiments. 
Recently, intravascular stents have been implanted 
in humans to prevent occlusion and restenosis after 
PTCA.ll The endoprosthesis used in this first clinical 
series consisted of a new self-expandable stainless- 
steel mesh.ll The early assessment immediately after 
stent implantation showed an additional morphologic 
improvement over the PTCA results, affecting both the 
stenotic and nonstenotic segments, which demon- 
strates the intrinsic dilating force of the stent. Sigwart 
et all1 have indicated that this prosthesis has an elastic 
radial force that tends to dilate the artery when the 
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MLCA (mm2) 
t 
Pre-PTCA Post-STENT After 3 months 
FIGURE 5. Changes in minimal luminal cross-sectional area 
(MLCA) between pre-angioplasty (pre-PTCA) and immediately af- 
ter stent implantation (post-WENT) and after a a-month follow-up. 
vessel caliber is less than that of uncontrained stent 
diameter. Dilatation continues until an equilibrium is 
achieved between the circumferential elastic resis- 
tance bf the arterial wall and the dilating force of the 
prosthesis. Previously, Wright et all0 showed that the 
expansile pressure depends on the recipient vessel 
diameter and on the intrinsic dilating force of the stent 
itself. The present study confirms-in human beings- 
the dilating capacity of the stent. 
In this study, changes in the nonstenotic segments 
are reflected in the significant increase observed in the 
interpolated reference diameter after stent implanta- 
tion. In the interpretation f this result, 3 facts have to 
be considered with regard to the determination of the 
reference diameter. 
First, the “interpolated” technique for the determi- 
nation of the reference diameter incorporates in its 
computation all the individual diameter values of the 
proximal and distal coronary segments, which itivari& 
ably include stented, but nonstenotic segments. Sec- 
ond, the stent size is selected so as to have in its uncon- 
strained state a diameter 0.5 mm larger than the vessel 
in which it is to be implanted, to ensure that the device 
will be securely anchored. Third, as the stent has a 
length ranging from 15 to 22 mm, it is not surprising 
that the radial force exerted by the stent has a dilating 
effect on the fionstenotic Segments included in the 
computation of the interpolated reference diameter. 
All the long-term experimental studies have shown 
that in animals neointimal proliferation produces a 
covering of the stent’s luminal surface. The time taken 
for the endothelialization process to cover the stent 
surface depends on the thickness of the wire fila- 
ments7,8~10~11 (3 weeks for the prosthesis used in this 
study).ll Neointimal thickening varies from 0.2 to 0.5 
mmgsll and depends on the diameter of the prosthesis.8 
However, most investigators have not found important 
angiographic reductions in vessel diameter after stent 
implantation,4~8~10~*1 except for Dotter in his initial 
study.5 In a previous study with conventional analysis 
of in vivo arteriograms, neointimal thickening was not 
described.g In contradistinction, our study demon- 
strates that a small diffuse narrowing of the vessel’s 
lumen is detectable by quantitative coronary angiogra- 
phy. In the present study, neointimal proliferation was 
estimated to produce a 0.200-mm reduction in vessel 
diameter, corresponding to a 11 f 3% reduction in the 
stenotic percentage diameter. These results are consis- 
tent with animal studies on neointimal thickeninggvll 
occurring after stent implantation. 
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